Adolescent perspectives on phase I cancer research

Pediatric Blood and Cancer

Volumn 60, Issue 5, 2013, Pages 873-878

  Miller, Victoria A ^a   Baker, Justin N ^b   Leek, Angela C ^c   Hizlan, Sabahat ^c   Rheingold, Susan R ^a   Yamokoski, Amy D ^c   Drotar, Dennis ^d   Kodish, Eric ^c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Decision making; Ethics; Informed consent; Oncology; Pediatrics; Phase I

Indexed keywords

ADOLESCENT; ADULT; ANDROBLASTOMA; ARTICLE; BONE CANCER; BRAIN CANCER; CANCER RESEARCH; CLINICAL ARTICLE; DECISION MAKING; FEMALE; HUMAN; LEUKEMIA; MALE; OPEN ENDED QUESTIONNAIRE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; SOFT TISSUE CANCER; STRUCTURED INTERVIEW;

ADOLESCENT; CLINICAL TRIALS, PHASE I AS TOPIC; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT BY MINORS; MALE; NEOPLASMS; PATIENT PARTICIPATION; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84874977882     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24326     Document Type: Article

References (28)

1. Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and Whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996;88:812-816.
2. Baker JN, Wang C, Yang J, et al. A comparison of end-of-life characteristics of pediatric cancer patients who participated in a Phase I clinical trial versus those who did not. In: American Academy of Hospice and Palliative Medicine Annual Assembly. Vancouver, 2011.
3. Moore S. A need to try everything: Patient participation in phase I trials. J Adv Nurs 2001;33:738-747.
4. Agrawal M, Emanuel EJ. Ethics of Phase 1 oncology studies: Reexamining the arguments and data. J Am Med Assoc 2003;290:1075-1082.
5. Oberman M, Frader J. Dying children and medical research: Access to clinical trials as benefit and burden. Am J Law Med 2003;29:301-317.
6. Weinfurt KP, Castel LD, Li Y, et al. The correlation between patient characteristics and expectations of benefit from phase I clinical trials. Cancer 2003;98:166-175.
7. Nurgat ZA, Campbell NC, Bissett JD, et al. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer 2005;92:1001-1005.
8. Pentz RD, White M, Harvey RD, et al. Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer 2012;118:4571-4578.
9. Sulmasy DP, Astrow AB, He MK, et al. The culture of faith and hope: Patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer 2010;116:3702-3711.
10. Catt S, Langridge C, Fallowfield L, et al. Reasons given by patients for participating, or not, in phase 1 cancer trials. Eur J Cancer 2011;47:1490-1497.
11. Hinds PS, Drew D, Oakes LL, et al. End-of-life care preferences of pediatric patients with cancer. J Clin Oncol 2005;23:9146-9154.
12. Barrera M, D'Agostino N, Gammon J, et al. Health-related quality of life and enrollment in Phase 1 trials in children with incurable cancer. Palliat Support Care 2005;3:191-196.
13. Cousino MK, Zyzanski SJ, Yamokoski AD, et al. Communicating and understanding the purpose of pediatric phase 1 cancer trials. J Clin Oncol (in press).
14. Lee DP, Skolnik JM, Adamson PC. Pediatric phase I trials in oncology: An analysis of study conduct efficiency. J Clin Oncol 2005;23:8431-8441.
15. Shah S, Weitman S, Langevin AM, et al. Phase I therapy trials in children with cancer. J Pediatr Hematol Oncol 1998;20:431-438.
16. Miller M. Phase I cancer trials: A collusion of misunderstanding. Hastings Center Report 2000;30:34-42.
17. Sankar P. Communication and miscommunication in informed consent to research. Med Anthropol Q 2004;18:429-446.
18. Bluebond-Langner M, DeCicco A, Belasco J. Involving children with life-shortening illnesses in decisions about participation in clinical research: A proposal for shuttle diplomacy and negotiation. In: Kodish E, editor. Ethics, research with children: A case-based approach. New York: Oxford; 2005. pp. 323-343.
19. Yap TY, Yamokoski AD, Hizlan S, et al. Informed consent for pediatric phase 1 cancer trials: Physicians' perspectives. Cancer 2010;116:3244-3250.
20. de Vries MC, Wit JM, Engberts DP, et al. Pediatric oncologists' attitudes towards involving adolescents in decision-making concerning research participation. Pediatr Blood Cancer 2010;55:123-128.
21. Krantz DS, Baum A, Wideman M. Assessment of preferences for self-treatment and information in health care. J Pers Soc Psychol 1980;39:977-990.
22. Tait AR, Voepel-Lewis T, Munro HM, et al. Parents' preferences for participation in decisions made regarding their child's anaesthetic care. Pediatr Anaesth 2001;11:283-290.
23. Joffe S, Fernandez CV, Pentz RD, et al. Involving children in decision-making about research participation. J Pediatr 2006;149:862-868.
24. Reder EA, Serwint JR. Until the last breath: Exploring the concept of hope for parents and health care professionals during a child's serious illness. Arch Pediatr Adolesc Med 2009;163:653-657.
25. Irving LM, Snyder CR, Crowson JJ. Hope and coping with cancer by college women. J Pers 1998;66:195-214.
26. Snethen JA, Broome ME, Knafl K, et al. Family patterns of decision-making in pediatric clinical trials. Res Nurs Health 2006;29:223-232.
27. Broome ME, Richards DJ. The influence of relationships on children's and adolescents' participation in research. Nurs Res 2003;52:191-197.
28. Kodish E. Pediatric ethics and early-phase childhood cancer research: Conflicted goals and the prospect of benefit. Account Res 2003;10:17-25.